Mixed valvular heart disease: diagnosis and management.

Philippe Unger, Philippe Pibarot, Xavier Galloo

Journal: European heart journal 2025;46(24):2261-2274

PMID: 40036874

Abstract

Mixed valvular diseases (MVDs) are common but have received little attention in the literature, especially regarding the mitral valve (MV) and the right-sided cardiac valves. Whereas echocardiography plays a pivotal diagnostic role, the diagnosis is made difficult due to haemodynamic interactions that may invalidate common indices of severity used in isolated stenosis or regurgitation. The diagnostic strategy should aim at initially separately assessing stenosis and regurgitation, taking into account the diagnostic pitfalls, with complementary use of multimodality imaging in cases of persisting diagnostic uncertainties. Unlike aortic stenosis, the calcium score cannot be used as a surrogate for haemodynamic severity of mixed MV disease. Severe stenosis and/or severe regurgitation are indicative of severe MVD, and management should follow recommendations on the predominant lesion. However, some patients with the combination of moderate stenosis and moderate regurgitation have a poor prognosis when left untreated. Concordant data suggest that, in patients with mixed aortic or MV disease, transvalvular velocities and pressure gradients are more powerful prognostic indicators than valve area or the severity of regurgitation. It is essential to consider the global repercussions that indicate poor outcomes in patients with MVD. However, whereas symptoms and/or ventricular dysfunction are considered as clear indication for intervention, imaging cut-offs have not been validated for balanced moderate regurgitation and stenosis. Although emerging evidence tends to support earlier management, further prospective studies are required, and pending the results of these studies, asymptomatic patients with MVD should be closely monitored.

© The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact [email protected] for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected].

Address: Department of Cardiology, Université Libre de Bruxelles (ULB), CHU Saint-Pierre, 322, Rue Haute, Brussels B-1000, Belgium.; Department of Cardiology, Vrije Universiteit Brussel (VUB)-Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, Brussels B-1090, Belgium.; Department of Cardiology, Vrije Universiteit Brussel (VUB)-Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, Brussels B-1090, Belgium.; Department of Medicine, Québec Heart and Lung Institute, Laval University, Québec City, Québec, Canada.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.